- Home
- PRSO vs SCNI Comparison
PRSO vs SCNI Comparison
Compare PRSO & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRSO
- SCNI
- Stock Information
- Founded
- PRSO 2008
- SCNI 2003
- Country
- PRSO United States
- SCNI Israel
- Employees
- PRSO N/A
- SCNI N/A
- Industry
- PRSO Semiconductors
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PRSO Technology
- SCNI Health Care
- Exchange
- PRSO Nasdaq
- SCNI Nasdaq
- Market Cap
- PRSO 3.3M
- SCNI 2.8M
- IPO Year
- PRSO 2001
- SCNI N/A
- Fundamental
- Price
- PRSO $0.94
- SCNI $3.52
- Analyst Decision
- PRSO Strong Buy
- SCNI
- Analyst Count
- PRSO 2
- SCNI 0
- Target Price
- PRSO $3.38
- SCNI N/A
- AVG Volume (30 Days)
- PRSO 76.9K
- SCNI 20.5K
- Earning Date
- PRSO 03-17-2025
- SCNI 11-22-2024
- Dividend Yield
- PRSO N/A
- SCNI N/A
- EPS Growth
- PRSO N/A
- SCNI N/A
- EPS
- PRSO N/A
- SCNI 8.20
- Revenue
- PRSO $12,728,000.00
- SCNI $452,000.00
- Revenue This Year
- PRSO $9.59
- SCNI N/A
- Revenue Next Year
- PRSO $1.63
- SCNI N/A
- P/E Ratio
- PRSO N/A
- SCNI $0.43
- Revenue Growth
- PRSO N/A
- SCNI N/A
- 52 Week Low
- PRSO $0.73
- SCNI $2.23
- 52 Week High
- PRSO $2.34
- SCNI $8.92
- Technical
- Relative Strength Index (RSI)
- PRSO 50.19
- SCNI 52.91
- Support Level
- PRSO $0.82
- SCNI $3.30
- Resistance Level
- PRSO $0.92
- SCNI $3.60
- Average True Range (ATR)
- PRSO 0.07
- SCNI 0.25
- MACD
- PRSO 0.02
- SCNI -0.01
- Stochastic Oscillator
- PRSO 60.38
- SCNI 44.05
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.